Guidelines: Acute coronary syndrome (ACS)

[1] Andersen H.R., Nielsen T.T., Rasmussen K., Et al., The Danish multicenter randomized trial on thrombolytic therapy versus acute coronary angioplasty in acute myocardial infarction, New Engl J Med, 8, pp. 349-356, (2003)

[2] Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, pp. 103-105, (2002)

[3] Antman E.M., Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial, Lancet, 360, pp. 1189-1196, (2002)

[4] Antman E.M., Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial, Circulation, 94, pp. 911-921, (1996)

[5] Antman E.M., Louwerenburg H.W., Baars H.F., Et al., Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial, Circulation, 105, pp. 1642-1649, (2002)

[6] Antoniucci D., Santoro G.M., Bolognese L., Et al., A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial, J Am Coll Cardiol, 31, pp. 1234-1239, (1998)

[7] Armstrong P.W., Wagner G., Goodman S.G., Van De Werf F., Granger C., Wallentin L., Fu Y., ST segment resolution in ASSENT 3: Insights into the role of three different treatment strategies for acute myocardial infarction, Eur Heart J, 24, pp. 1515-1522, (2003)

[8] Arntz H.R., Tebbe U., Schuster H.P., Sauer G., Meyer J., Leitlinien zu Diagnostik und Therapie des akuten Herzinfarktes in der Prähospitalphase, Z Kardiol, 89, pp. 364-372, (2000)

[9] Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial, Lancet, 354, pp. 716-722, (1999)

[10] Berger A.K., Radford M.J., Wang Y., Krumholz H.M., Thrombolytic therapy in older patients, J Am Coll Cardiol, 36, pp. 366-374, (2000)

[1] Andersen H.R., Nielsen T.T., Rasmussen K., Et al., The Danish multicenter randomized trial on thrombolytic therapy versus acute coronary angioplasty in acute myocardial infarction, New Engl J Med, 8, pp. 349-356, (2003)

[2] Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, pp. 103-105, (2002)

[3] Antman E.M., Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial, Lancet, 360, pp. 1189-1196, (2002)

[4] Antman E.M., Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial, Circulation, 94, pp. 911-921, (1996)

[5] Antman E.M., Louwerenburg H.W., Baars H.F., Et al., Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial, Circulation, 105, pp. 1642-1649, (2002)

[6] Antoniucci D., Santoro G.M., Bolognese L., Et al., A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial, J Am Coll Cardiol, 31, pp. 1234-1239, (1998)

[7] Armstrong P.W., Wagner G., Goodman S.G., Van De Werf F., Granger C., Wallentin L., Fu Y., ST segment resolution in ASSENT 3: Insights into the role of three different treatment strategies for acute myocardial infarction, Eur Heart J, 24, pp. 1515-1522, (2003)

[8] Arntz H.R., Tebbe U., Schuster H.P., Sauer G., Meyer J., Leitlinien zu Diagnostik und Therapie des akuten Herzinfarktes in der Prähospitalphase, Z Kardiol, 89, pp. 364-372, (2000)

[9] Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial, Lancet, 354, pp. 716-722, (1999)

[10] Berger A.K., Radford M.J., Wang Y., Krumholz H.M., Thrombolytic therapy in older patients, J Am Coll Cardiol, 36, pp. 366-374, (2000)